- Open Access
The evaluation of microbiology and prognosis of fournier’s gangrene in past five years
© Tang et al.; licensee Springer. 2015
- Received: 4 November 2014
- Accepted: 30 December 2014
- Published: 13 January 2015
Fournier’s gangrene (FG) is an devastating disease that affects the perineum and genitourinary region, and is commonly a result of poly-microbial infection. This study is aimed to determine the correlation between micrology and prognosis of FG in the past five years.
This study was a retrospective cohort study that was designed to study the trends in micrology and prognosis of FG. From the PubMed database, articles published in the recent 5 years (from Jan1st, 2009 to Dec 31st, 2013) were reviewed. A total of 19 articles (each with n > 30 and with thorough data descriptions in the topic of Fournier's gangrene), were enrolled in this study. The consolidated data was further analyzed by commercial statistical software (SPSS for Windows).
The twenty-two studies have covered FG cases from year 1981 to 2011, with a mean duration of 9.2 years. The total number of cases is 4,365. Majority of the cases are male (84.1%). The mean age and mortality rate is 51.8 ± 5 years old and 11.1 ± 8.9%, respectivly. The most commonly found pathogen is poly-microbial organism (54%), followed by Escherichia coli (46.6%) and Streptococcus (36.8%). The major risk factors are diabetes (43.7%), Body mass index of > 30 (40.7%), and hypertension (38.1%). Mortality rate in older patient group (age > 51.8 years old) is significantly higher than those of the younger group (22% vs. 5.5%, p = 0.0001).
Older patients with genital or perineal pain should be examined for crepitus dermis. When a patient is diagnosed with FG, swift consultation with surgeons and administration of broad-spectrum antibiotics are required in order to save the patient’s live.
- Escherichia coli
- Fournier’s Gangrene
Fournier’s gangrene (FG) is a devastating necrotising disease that affects the perineum and genitourinary regions. The common cause of FG is poly-microbial infections, where the diabetes mellitus is an attributing common risk factor (Shyam and Rapsang ). Study has shown that males, especially in their 60 to 70s, are more often affected by FG when compared to other populations (Rodríguez Alonso et al. ). Aside from diabetes, other risk factors of FG also include chronic alcoholism, renal failure, and obesity (Montoya Chinchilla et al. ). The majorities of FG studies have shown that early diagnosis and aggressive management of FG are required to significantly improve patient outcome. Due to the fact that FG is not a common disease, a prospective study is difficult to perform. Therefore, In this study, a large number of FG cases that have occurred in the past five years are gathered by retrospective literature review and analyzed to determined the relationship between micrology and prognosis of FG.
There were 19 articles (from January 1, 2009 to December 31, 2013) enrolled into this study
Mortality rate %
1981 ~ 2010
Martinschek et al. ()
1994 ~ 2006
Macro et. al. ()
1995 ~ 2010
Sallami et a. ()
1995 ~ 2010
Altarac et al. ()
1996 ~ 2006
Yilmazlar et al. ()
1996 ~ 2006
Ozturk et al. ()
1996 ~ 2008
Czymek et al. ()
1998 ~ 2006
MEHL et al. ()
1999 ~ 2009
Koukouras et al. ()
2000 ~ 2008
Malik et al. ()
2000 ~ 2008
Chen et al. ()
2001 ~ 2004
Sorensen et al. ()
2001 ~ 2011
Roghmann et al. ()
2002 ~ 2007
Morua et al. ()
2002 ~ 2007
Ullah et al. ()
2003 ~ 2008
Vargas et al. ()
2004 ~ 2010
GÖKTAŞ et al. ()
2004 ~ 2011
Bjurlin et al. ()
2005 ~ 2008
Ersoz et al. ()
The twenty-two studies have covered FG cases from year 1981 to 2011, with a mean duration of 9.2 years. The total number of cases is 2,656. Majority of cases are male (84.1%) and female is accounted for 15.9%.
Fournier’s gangrene (FG) is a rare emergent condition that affects the perineum and urogenital region. The clinical course of FG is fulminant and serious regardless of parenteral antibiotic treatment. The median time from syptom presentations to skin gangrenous change is 6 days (Altarac et al. ). When managing FG patients, this gangrenous tissue requires extensive and repeated debridement (Sallami et al. ). Several literatures have shown that patients with diabetes, old age, low blood pressure, high creatine kinase, high lactate, abdominal affection, hemoglobin of less than 10 g/dL, and platelet count of less than 150 × 109/L are associated with poor outcomes (Martinschek et al. ; Ruiz-Tovar et al. ).
Many literatures have determined that the risk factors of FG include diabetes mellitus, hypertension, heart disease, smoking, long-term steroid therapy, alcoholism or alcohol abuse, in hot and humid season, and renal failure (Martinschek et al. ; Sallami et al. ; Czymek et al. ; Mehl et al. ; Malik et al. ; Ullah and Khan ). Out of the many risk factors, diabetes mellitus is still the highest influencing factor on FG where 43.7% of FG patients are diabetic. A report by Czymek et. al. showed that being overweight is also a risk factor of FG, where nearly 40 % of FG patients have body mass indexes (BMIs) of higher than 30 (Czymek et al. ; Mehl et al. ). Although there are several known risk factors that can lead to the development of FG, the clinical onset of FG is still unpredictable.
The most common symptoms of FG are perineal pain and fever that are accompanied by swelling and reddening of perineum or genital area, and the gangreneous change of overlaying skin (Ruiz-Tovar et al. ).
The most common microbiology involved in FG is poly-microbial infection (54%), and the most common found pathogen isolate is Escherichia coli (46.6%). Others contributing pathogen are Streptococcal infection, Bacteroides, Enterobacter, Staphylococcus, Enterococcus, Pseudomonas, Corynebacterium, and Klebsiella pneumoniae (Rodríguez Alonso et al. ; Czymek et al. ; Mehl et al. ). Broad-spectrum antibiotic treatment is suggested to adequately cover poly-microbial pathogen, and careful patient monitoring is required to avoid is fungal or hospital-acquired pathogen infection (Bjurlin et al. ).
In terms of gender, there was no significant mortality rate that was found between the genders (Ersoz et al. ). A study from Spain (n = 51) showed that the survivors of FG are 13.5 years younger than those who have died (60 versus 73.5, p = 0.02) (Luján Marco et al. ). In a 2012 report from Turkey ( n = 52), the non-survivors group are older in age than survivors (62 versus 55 years old]. In our study, the results also showed that the older patients age had higher rates of mortality. This result is concurrent with in the other previous studies, where increased age was shown to be related to higher mortality rate (Martinschek et al. ; Roghmann et al. ).
Although FG is rare, its rapid progression can lead to life-threatening conditions that require early surgical intervention and parenteral antibiotics to improve patient outcomes (Morua et al. ). The mortality rate of FG remains high and ranges from 4.9 to 36.6% in the recent five years. Due to its high mortality rate and rapid progress, FG must be regarded in clinical settings. The reduction of obesity, alcohol consumption, tobacco use is helpful in reducing the possible risk of FG. Furthermore, older patients with genital or perineal pain should be examined for crepitus dermis. Finally, when a patient is diagnosed with FG, swift consultation with surgeons and administration of broad-spectrum antibiotics are required in order to save the patient’s live.
Dr. Lap-Ming Tang and Dr. Yu-Jang Su are senior attending physicians worked at Department of Emergency Medicine, Mackay Memorial Hospital, Taipei 10449, Taiwan. Dr. Yu-Jang Su is also awarded six times of best teacher of Mackay Memorial Hospital, Taipei till 2014, and teaches at department of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan as an Assistant Professor. Dr. Yen-Chun Lai is a professional anesthesiologist working at Department of Anesthesiology, Taiwan Adventist Hospital, Taipei, Taiwan. We all have copious clinical experiences in practice.
- Altarac S, Katušin D, Crnica S, Papeš D, Rajković Z, Arslani N: Fournier’s gangrene: etiology and outcome analysis of 41 patients. Urol Int 2012, 88(3):289-293. 10.1159/000335507View ArticleGoogle Scholar
- Bjurlin MA, O’Grady T, Kim DY, Divakaruni N, Drago A, Blumetti J, Hollowell CM: Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier’s gangrene. Urology 2013, 81(4):752-758. 10.1016/j.urology.2012.12.041View ArticleGoogle Scholar
- Chen SY, Fu JP, Chen TM, Chen SG: Reconstruction of scrotal and perineal defects in Fournier’s gangrene. J Plast Reconstr Aesthet Surg 2011, 64(4):528-534. 10.1016/j.bjps.2010.07.018View ArticleGoogle Scholar
- Czymek R, Frank P, Limmer S, Schmidt A, Jungbluth T, Roblick U, Bürk C, Bruch HP, Kujath P: Fournier’s gangrene: is the female gender a risk factor? Langenbecks. Arch Surg 2010, 395(2):173-180. 10.1007/s00423-008-0461-9View ArticleGoogle Scholar
- Ersoz F, Sari S, Arikan S, Altiok M, Bektas H, Adas G, Poyraz B, Ozcan O: Factors affecting mortality in Fournier’s gangrene: experience with fifty-two patients. Singapore Med J 2012, 53(8):537-540.Google Scholar
- Göktaş C, Yıldırım M, Horuz R, Faydacı G, Akça O, Cetinel CA: Factors affecting the number of debridements in Fournier’s gangrene: our results in 36 cases. Ulus Travma Acil Cerrahi Derg 2012, 18(1):43-48. 10.5505/tjtes.2012.36599View ArticleGoogle Scholar
- Koukouras D, Kallidonis P, Panagopoulos C, Al-Aown A, Athanasopoulos A, Rigopoulos C, Fokaefs E, Stolzenburg JU, Perimenis P, Liatsikos E: Fournier’s gangrene, a urologic and surgical emergency: presentation of a multi-institutional experience with 45 cases. Urol Int 2011, 86(2):167-172. 10.1159/000321691View ArticleGoogle Scholar
- Luján Marco S, Budía A, Di Capua C, Broseta E, Jiménez CF: Evaluation of a severity score to predict the prognosis of Fournier’s gangrene. BJU Int 2010, 106(3):373-376. 10.1111/j.1464-410X.2009.09075.xView ArticleGoogle Scholar
- Malik AM, Sheikh S, Pathan R, Khan A, Sheikh U: The spectrum of presentation and management of Fournier’s gangrene–an experience of 73 cases. J Pak Med Assoc 2010, 60(8):617-619.Google Scholar
- Martinschek A, Evers B, Lampl L, Gerngroß H, Schmidt R, Sparwasser C: Prognostic aspects, survival rate, and predisposing risk factors in patients with Fournier’s gangrene and necrotizing soft tissue infections: evaluation of clinical outcome of 55 patients. Urol Int 2012, 89(2):173-179. 10.1159/000339161View ArticleGoogle Scholar
- Mehl AA, Nogueira Filho DC, Mantovani LM, Grippa MM, Berger R, Krauss D, Ribas D: Management of Fournier’s gangrene: experience of a university hospital of Curitiba. Rev Col Bras Cir 2010, 37(6):435-441.Google Scholar
- Montoya Chinchilla R, Izquierdo Morejon E, Nicolae Pietricicâ B, Pellicer Franco E, Aguayo Albasini JL, Miñana LB: Fournier’s gangrene. Descriptive analysis of 20 cases and literature review. Actas Urol Esp 2009, 33(8):873-880. 10.1016/S0210-4806(09)72875-XView ArticleGoogle Scholar
- Morua AG, Lopez JA, Garcia JD, Montelongo RM, Guerra LS: Fournier’s gangrene: our experience in 5 years, bibliographic review and assessment of the Fournier’s gangrene severity index. Arch Esp Urol 2009, 62(7):532-540.Google Scholar
- Ozturk E, Sonmez Y, Yilmazlar T: What are the indications for a stoma in Fournier’s gangrene? Colorectal Dis 2011, 13(9):1044-1047. 10.1111/j.1463-1318.2010.02353.xView ArticleGoogle Scholar
- Rodríguez Alonso A, Pérez García MD, Núñez López A, Ojea Calvo A, Alonso Rodrigo A, Rodríguez Iglesias B, Barros Rodríguez JM, Benavente Delgado J, Nogueira March JL: Fournier’s gangrene: anatomo-clinical features in adults and children. Therapy update Actas Urol Esp 2000, 24(4):294-306. 10.1016/S0210-4806(00)72452-1View ArticleGoogle Scholar
- Roghmann F, von Bodman C, Löppenberg B, Hinkel A, Palisaar J, Noldus J: Is there a need for the Fournier’s gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier’s gangrene. BJU Int 2012, 110(9):1359-1365. 10.1111/j.1464-410X.2012.11082.xView ArticleGoogle Scholar
- Ruiz-Tovar J, Córdoba L, Devesa JM: Prognostic factors in Fournier gangrene. Asian J Surg 2012, 35(1):37-41. 10.1016/j.asjsur.2012.04.006View ArticleGoogle Scholar
- Sallami S, Maalla R, Gammoudi A, Ben Jdidia G, Tarhouni L, Horchani A: Fournier’s gangrene: what are the prognostic factors? Our experience with 40 patients. Tunis Med 2012, 90(10):708-714.Google Scholar
- Shyam DC, Rapsang AG: Fournier’s gangrene. Surgeon 2013, 11(4):222-232. 10.1016/j.surge.2013.02.001View ArticleGoogle Scholar
- Sorensen MD, Krieger JN, Rivara FP, Broghammer JA, Klein MB, Mack CD, Wessells H: Fournier’s Gangrene: population based epidemiology and outcomes. J Urol 2009, 181(5):2120-2126. 10.1016/j.juro.2009.01.034View ArticleGoogle Scholar
- Ullah S, Khan M, Asad Ullah Jan M: Fournier’s gangrene: a dreadful disease. Surgeon 2009, 7(3):138-142. 10.1016/S1479-666X(09)80036-XView ArticleGoogle Scholar
- Vargas AH, Carbonell J, Osorio D, García HA: Evaluation of Fournier’s necrosis in a high complexity hospital. Arch Esp Urol 2011, 64(10):948-952.Google Scholar
- Yilmazlar T, Ozturk E, Ozguc H, Ercan I, Vuruskan H, Oktay B: Fournier’s gangrene: an analysis of 80 patients and a novel scoring system. Tech Coloproctol 2010, 14(3):217-223. 10.1007/s10151-010-0592-1View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.